chr6-162727665-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_004562.3(PRKN):c.4A>G(p.Ile2Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000695 in 1,583,762 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004562.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000132  AC: 2AN: 152074Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000155  AC: 3AN: 193568 AF XY:  0.00000951   show subpopulations 
GnomAD4 exome  AF:  0.00000629  AC: 9AN: 1431688Hom.:  0  Cov.: 30 AF XY:  0.00000705  AC XY: 5AN XY: 709702 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000132  AC: 2AN: 152074Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 74290 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with PARK2-related disease. This variant is present in population databases (rs747682986, ExAC 0.01%). This sequence change replaces isoleucine with valine at codon 2 of the PARK2 protein (p.Ile2Val). The isoleucine residue is weakly conserved and there is a small physicochemical difference between isoleucine and valine. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at